As part of Boehringer Ingelheim’s Stop Rabies program, pet owners bring their pets for careful assessment and verification of previous vaccination records to ensure they receive the necessary immunizations during the mass vaccination drive at The Clubhouse in Filinvest 2, Quezon City in partnership with Magic 89.9.

               

In photo, from left to right: Dr. Vincent Casimero, Technical and Marketing Lead of Companion Animals at Boehringer Ingelheim Animal Health Philippines, Inc., and veterinarians and volunteers from Boehringer and Bureau of Animal Industry (BAI) administer free rabies vaccinations to pets at The Clubhouse at Filinvest 2, Quezon City, as part of the Stop Rabies program. This initiative aims to protect pets and communities by promoting rabies prevention and responsible pet ownership.

 

 

 Boehringer Ingelheim (Philippines), Inc. expands its Stop Rabies program with a mass vaccination drive at The Clubhouse in Filinvest 2, Quezon City to mark Rabies Awareness Month. The initiative provided free pet vaccinations, reinforcing the importance of responsible pet ownership and strengthening community-wide rabies prevention efforts. With support from the Bureau of Animal Industry and Magic 89.9 FM’s Pets in the City radio program, veterinarians and volunteers worked together to educate pet owners on the crucial role of vaccination in eliminating rabies and safeguarding public health. Through this vaccination drive, Boehringer Ingelheim remains committed to making vaccinations accessible and building safer, rabies-free communities in the Philippines. For more information about Boehringer Ingelheim’s rabies prevention initiatives, visit https://www.boehringer-ingelheim.com/animal-health.

 

 

Boehringer Ingelheim

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term, sustainable perspective. More than 53,000 employees serve over 130 markets in the two business units Human Pharma and Animal Health. Learn more at www.boehringer-ingelheim.com

 

Boehringer Ingelheim - Animal Health business  

Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society.